Shanmuga Hospital Limited
CLOSEDIPO Date: 13 Feb - 17 Feb 2025
Listing Date: 20 Feb 2025
Price Range
₹54 - ₹54
Issue Size
21 Cr
Min Investment
₹1,08,000
Lot Size
2000 Shares
Schedule of Shanmuga Hospital Limited
Issue open date
13 Feb 2025
Issue close date
17 Feb 2025
UPI mandate deadline
17 Feb 2025 (5 PM)
Allotment finalization
18 Feb 2025
Share credit
19 Feb 2025
Listing date
20 Feb 2025
Mandate end date
4 Mar 2025
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 21 Cr |
| Fresh Issue | 20.62 Cr |
| Offer for Sale | 0 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 18 Feb 2025 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 13 Feb 2025 | ₹54 | ₹8 | ₹62 (14.81%) |
| 12 Feb 2025 | ₹54 | ₹8 | ₹62 (14.81%) |
| 11 Feb 2025 | ₹54 | ₹8 | ₹62 (14.81%) |
Performance Shanmuga Hospital Limited
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹54 - ₹54 | .... | ₹ 36.31 | -32.76% |
About Shanmuga Hospital Limited
Shanmuga Hospital Limited, established in 1981 as a sole proprietorship in Salem, Tamil Nadu, was later incorporated as Shanmuga Hospital Private Limited in 2020. Over the years, it has grown into a multispecialty hospital, offering a broad range of medical services with specialties in oncology, cardiac care, critical care, and surgical procedures. With 151 beds, the facility includes an Oncology Unit, Intensive Care Unit (ICU), Neonatal ICU (NICU), Emergency Department (ED), High Dependency Unit (HDU), and advanced diagnostic and imaging services such as MRI, CT scan, and X-ray. The hospital is NABH and NABL accredited, ensuring high standards of healthcare. It continues to expand its facilities and enhance its capabilities, solidifying its position as a leading regional healthcare provider.
| Founded in | 1981 |
| Managing director | |
| Parent organization | Shanmuga Hospital Ltd |
Financial Overview
Strengths
- Strong oncology department with advanced treatment technology.
- Promoters have over four decades of healthcare experience.
- Affordable healthcare services for the regional population.
- Cutting-edge medical equipment including LINAC, MRI.
- Strategic tie-ups with government and insurance companies.
Risks
- Legal proceedings could impact business operations and reputation.
- High dependency on key personnel and specialists.
- Regulatory changes may impact profitability and operations.
- Competition from other hospitals and healthcare providers.
- Operational risks due to medical equipment failures.
- Failure to maintain service quality may harm reputation.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | N/A |
| Non-Institutional Investors (NIIs) | 0.19 |
| Retail Individual Investors (RIIs) | 1.11 |
| Employee | N/A |
| Total | 0.65 |